Issue 65 March - April 2015

Side effects of targeted treatments: clinicians' perceptions, patients' realities

The side effects of targeted drugs are poorly documented, and their impact on patients frequently seriously underestimated and undertreated. Efforts to address these issues could improve survival as well as quality of life.

Read More ...
Issue 65 March - April 2015

Walking the line between quick access and evidence

How do you decide which new cancer drugs to approve, when statistical certainty takes too long to wait for and essential evidence on quality of life is hard to measure? The head of the cancer section at the European Medicines Agency is keen to explain his approach.

Read More ...
Issue 65 March - April 2015

Better outcomes data lead to better outcomes

We need to greatly improve our ability to monitor the impact of treatments on outcomes.

Read More ...
Issue 64 January - February 2015

Caring for one of our own

When youÂ’re caring for a patient and friend, who was recently your colleague, working out boundaries and negotiating the particular privileges and pressures of caring for them can be hard. The problem was explored in a Schwartz Center Round* at the Massachusetts General Hospital.

Read More ...
Issue 64 January - February 2015

Lymphoedema following treatment for breast cancer: a new approach to an old problem

Screening breast cancer patients for lymphoedema makes it possible to identify problems early and take action to halt its progression. Oncologists have an important role to play, particularly given the rise in lymphoedema rates that may be expected due to greater use of regional radiotherapy in early breast cancer.

Read More ...